Life Sciences

Molecula gives life sciences the world-changing power of data access

Life sciences data scientists and analysts are playing increasingly important roles as they provide the analytics necessary to make time-sensitive decisions in competitive, dynamic environments. They need access to massive amounts of high velocity data in order to succeed. It’s not trivial to get vast amounts of complex data into a single place where it is interlinked and prepared for machine processing. Instead of spending their time exploring data and creating new analyses, too many data scientists and analysts are working overtime just to get access to the data.

Molecula for Life Sciences

Molecula is an enterprise feature store that simplifies, accelerates, and controls big data access to power machine-scale analytics and AI so organizations and companies can achieve their business objectives. With Molecula, life sciences companies are able to securely access and perform computations on any and all data at unprecedented speeds, with incredibly low latency, and with a fraction of the hardware.

Molecula empowers companies in the life sciences industry to:

Predict

outcomes in real-time by leveraging 100% of distributed data

Delight

users and drive adoption with zero latency

Enable

continuous analysis and machine learning with millisecond performance

Minimize

security and privacy risks with anonymized-ready data

Reduce

time and cost to get value from AI and machine learning

Use Cases

Identify

Genetic Mutations

With the ability to analyze all data across millions of cancer patients, mutations and patterns become visible for the first time.

Prevent

Epidemics

Big data access at scale empowers scientists to combine demographic, geographic, and socio-economic data along with disease trends and health strategies to prevent unnecessary illness in populations.

Predict

Virus evolution

Testing against massive databases, DNA sequencing helps in the discovery of new viruses.

Improve

Drug trial execution and success

Analyzing unlimited patient attributes and being able to slice and dice data across all trials, past and present, provides for more rigorous evaluation of side effects during trials.

https://www.molecula.com/wp-content/uploads/2020/11/elligo-1.png

"Our solution drives efficiency by enabling anonymized data from source to submission and full remote site access, empowering patients, physicians, and sponsors to conduct more trials efficiently and faster in traditional and decentralized models."

– John Potthoff, Ph.D., CEO of Elligo

Contact Us

Contact us today to learn more about how Molecula’s feature extraction and storage platform will transform your business. Ask us how you can unlock real-time value and actualize use cases never possible before.